WHITEHAWK THERAPEUTICS, INC. Proceeds from License Fees Received
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Proceeds from License Fees Received of $15.00 million for the 1-month period ending 2020-05-31, per its 10-Q filed 2021-08-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLicenseFeesReceived · last filed 2021-08-11
- 2020-05-31: Proceeds from License Fees Received 1 month $15.00M.
- 2020-05-12: Proceeds from License Fees Received $15.00M.
- 2018-06-28: Proceeds from License Fees Received $20.00M; Proceeds from License Fees Received 0 month $20.00M.
| Period end | Proceeds from License Fees Received | Proceeds from License Fees Received 0 month | Proceeds from License Fees Received 1 month |
|---|---|---|---|
| 2020-05-31 | $15.00M 10-Q · filed 2021-08-11 | ||
| 2020-05-12 | $15.00M 10-Q · filed 2021-08-11 | ||
| 2018-06-28 | $20.00M 10-Q · filed 2020-05-07 | $20.00M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |